Herceptin (Trastuzumab) - Life Threatening Events - Suspected Cause - Side Effect Reports

Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-21

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Cytomegaloviral

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Dosage: last dose prior to sae: 18/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-06-14

Paclitaxel
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Possible Herceptin side effects in 63 year old female

Reported by a physician from United Kingdom on 2012-08-20

Patient: 63 year old female, weighing 100.0 kg (220.0 pounds)

Reactions: Myalgia, Multi-Organ Failure, Malaise, Neutropenic Sepsis, Pain, Necrotising Fasciitis

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Indication: Breast Cancer Stage I
    Start date: 2010-04-30
    End date: 2010-05-24

Docetaxel
    Dosage: dose reduced,third dose not given.

Herceptin
    Indication: Breast Cancer Stage I

Other drugs received by patient: Cyclophosphamide; Fluorouracil; Dexamethasone; Epirubicin; Tinzaparin

Possible Herceptin side effects in female

Reported by a physician from Bosnia and Herzegowina on 2012-08-20

Patient: female, weighing 95.0 kg (209.0 pounds)

Reactions: Gastrointestinal Haemorrhage

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin

Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Haemorrhage Intracranial, Sepsis, Hypotension, Pneumonia Streptococcal, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Naproxen; Dexamethasone; Zometa; Dextrose; Ativan; Diphenhydramine HCL; Neulasta; Lortab; Robaxin; Fosphenytoin Sodium; Ciprofloxacin; Magnesium Sulfate; Lasix; Ferrous Sulfate TAB; Remeron; Artificial Tears; Amlodipine Besylate; Benadryl; Hydrocodone; Celexa; Acetaminophen; Lorazepam; Phenergan HCL; Potassium Chloride; Hydrocodone Bitartrate + Acetaminophen; Protonix; Aloxi; Mineral OIL; Insulin Aspart; Morphine Sulfate; Zofran; Cocaine; Udderly Smooth Cream

Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-16

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Sepsis, Pneumonia Streptococcal, Hypotension, Haemorrhage Intracranial, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Other drugs received by patient: Dexamethasone; Protonix; Zosyn; Insulin Aspart; Udderly Smooth Cream; Benadryl; Naproxen; Celexa; Aloxi; Diphenhydramine HCL; Zometa; Phenergan HCL; Acetaminophen; Fosphenytoin Sodium; Lortab; Lorazepam; Cocaine; Potassium Chloride; Ceftriaxone; Mineral OIL; Lasix; Levophed; Ferrous Sulfate TAB; Ciprofloxacin; Dextrose; Vancomycin HCL; Ativan; Neulasta; Robaxin; Artificial Tears; Hydrocodone; Remeron; Zofran; Hydrocodone Bitartrate + Acetaminophen; Magnesium Sulfate; Phenytoin Sodium

Possible Herceptin side effects in female

Reported by a physician from United States on 2012-08-15

Patient: female, weighing 57.6 kg (126.7 pounds)

Reactions: Abdominal Pain, Diarrhoea, Disseminated Intravascular Coagulation, Febrile Neutropenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Carboplatin
    Dosage: permanently discontinued
    End date: 2012-05-25

Carboplatin
    Dosage: temporarily discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Docetaxel
    Dosage: permanently discontinued
    End date: 2012-05-25

Docetaxel
    Dosage: permanently discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-04

Herceptin
    Dosage: permanently discontinued
    End date: 2012-05-25

Herceptin
    Dosage: maintanance dose, temporarily interrupted
    End date: 2012-05-04

Herceptin
    Dosage: loading dose, permanently discontinued
    Indication: Breast Cancer
    Start date: 2012-04-13

Pertuzumab
    Dosage: loading dose
    Indication: Breast Cancer
    Start date: 2012-04-13
    End date: 2012-05-25

Other drugs received by patient: Clindamycin; Lovaza; Tylenol; Zofran

Possible Herceptin side effects in 63 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-15

Patient: 63 year old female, weighing 100.0 kg (220.0 pounds)

Reactions: Myalgia, Multi-Organ Failure, Pain, Neutropenic Sepsis, Necrotising Fasciitis, Mobility Decreased

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: 100 mg/m2, unk
    Indication: Breast Cancer Stage I
    Start date: 2010-04-30

Docetaxel
    Dosage: 75 mg/m2, unk
    End date: 2010-05-25

Herceptin
    Indication: Breast Cancer Stage I
    Start date: 2010-05-21

Other drugs received by patient: Tinzaparin; Epirubicin; Dexamethasone; Fluorouracil; Cyclophosphamide

Possible Herceptin side effects in 74 year old female

Reported by a physician from United States on 2012-08-15

Patient: 74 year old female, weighing 72.0 kg (158.4 pounds)

Reactions: Myelodysplastic Syndrome

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 600 mg/m2 iv over 30 min, on day 1 q21 dayx 4, date of last drug taken prior to onset of ae:18/jun/2
    Indication: Breast Cancer
    Start date: 2002-04-08

Doxorubicin Hydrochloride
    Dosage: 60 mg/m2 intravenous push on day 1 every21 days x 4,date of last drug taken prior to onset of ae:18/
    Indication: Breast Cancer
    Start date: 2002-04-08

Herceptin
    Dosage: 4mg/kg over 90min (loading dose) on day1 of wk13 only,2mg/kg over 30 min (maintenance dose) qwk for
    Indication: Breast Cancer
    Start date: 2002-04-08

Paclitaxel
    Dosage: 175 mg/m2 over 3 hr q 21d starting day 1 of wk 13x 4, date of last drug taken prior to onset of ae:1
    Indication: Breast Cancer
    Start date: 2002-04-08

Possible Herceptin side effects in 58 year old female

Reported by a physician from China on 2012-08-14

Patient: 58 year old female

Reactions: Dyspnoea, Pleural Effusion, Pulmonary Embolism, Disease Progression

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin

Possible Herceptin side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-13

Patient: female, weighing 71.3 kg (156.8 pounds)

Reactions: Contusion, Gingival Bleeding, Petechiae

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin

Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-10

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Cytomegaloviral

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Dosage: last dose prior to sae: 18/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: last dose prior to sae: 14/jun/2012
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Dosage: last dose prior to sae: 02/jul/2012
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-08-06

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Multi-Organ Disorder, Pulmonary Mycosis

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: 750 milligram daily;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Other drugs received by patient: Acetaminophen; Thyranojod

Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-08-03

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Febrile Neutropenia, Duodenal Ulcer, Hepatic Failure, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Mucosta; Fluconazole; Acetaminophen; Tinzaparin; Tranexamic Acid; Omeprazole; Ciprofloxacin; Vitamin K TAB

Possible Herceptin side effects in 51 year old female

Reported by a consumer/non-health professional from Russian Federation on 2012-07-31

Patient: 51 year old female

Reactions: Product Counterfeit, Disease Progression

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Herceptin

Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-07-26

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Pneumonia Viral, Interstitial Lung Disease, Respiratory Failure, Pyrexia, Multi-Organ Disorder, Pulmonary Mycosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Herceptin
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Lapatinib
    Dosage: 750 milligram;
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2012-05-07

Paclitaxel
    Indication: Breast Cancer
    Start date: 2012-05-07
    End date: 2012-07-09

Other drugs received by patient: Thyranojod; Acetaminophen

Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-19

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Pneumonia Streptococcal, Sepsis, Haemorrhage Intracranial, Hypotension, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Possible Herceptin side effects in female

Reported by a physician from China on 2012-07-17

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Suicide Attempt, Neutropenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Avastin
    Dosage: last dose: 21 jul 2010
    Indication: Breast Cancer
    Start date: 2010-03-16
    End date: 2010-08-30

Carboplatin
    Dosage: last dose: 30 jun 2010
    Indication: Breast Cancer
    Start date: 2010-03-16

Clonazepam
    Indication: Product Used FOR Unknown Indication

Docetaxel
    Dosage: last dose: 30 jun 2010
    Indication: Breast Cancer
    Start date: 2010-03-16

Herceptin
    Dosage: last dose: 21 jul 2010
    Indication: Breast Cancer
    Start date: 2010-03-16
    End date: 2010-08-30

Possible Herceptin side effects in female

Reported by a physician from United States on 2012-07-17

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Hypotension, Sepsis, Haemorrhage Intracranial, Pneumonia Streptococcal, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-09

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Hypotension, Haemorrhage Intracranial, Sepsis, Pneumonia Streptococcal, Acute Respiratory Failure, Failure To Thrive, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-07-06

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Cardiac Failure, Cardiac Arrest, Cardiogenic Shock

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Fluorouracil
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Herceptin
    Indication: Breast Cancer
    Start date: 2007-08-10
    End date: 2007-08-10

Herceptin
    Dosage: dosage was decreased
    Start date: 2007-08-17
    End date: 2009-09-14

Other drugs received by patient: Nolvadex; Levothyroxine Sodium; Trichlormethiazide

Possible Herceptin side effects in female

Reported by a physician from Japan on 2012-07-05

Patient: female, weighing 65.0 kg (143.0 pounds)

Reactions: Cardiac Failure, Cardiogenic Shock, Cardiac Arrest

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Fluorouracil
    Indication: Breast Cancer
    Start date: 2007-03-27
    End date: 2007-07-10

Herceptin
    Indication: Breast Cancer
    Start date: 2007-08-10
    End date: 2007-08-10

Herceptin
    Dosage: dosage was decreased
    Start date: 2007-08-17
    End date: 2009-09-14

Other drugs received by patient: Nolvadex; Levothyroxine Sodium; Trichlormethiazide

Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-06-22

Patient: female, weighing 57.3 kg (126.1 pounds)

Reactions: Pneumonia Streptococcal, Haemorrhage Intracranial, Hypotension, Sepsis, Failure To Thrive, Acute Respiratory Failure, Convulsion

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 167 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Herceptin
    Dosage: last dose prior to sae 09/mar/2012, last dose taken: 344 mg
    Indication: Breast Cancer Metastatic
    Start date: 2012-01-06

Paclitaxel
    Dosage: last dose prior to sae: 09/mar/2012
    Indication: Breast Cancer Metastatic

Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-06-15

Patient: female, weighing 52.0 kg (114.4 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: dose level:100 mg/m2; last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Acetaminophen; Vitamin K TAB; Fluconazole; Mucosta; Ciproflaxacin; Omeprazole; Tranexamic Acid; Tinzaparin

Possible Herceptin side effects in female

Reported by a physician from Germany on 2012-06-13

Patient: female, weighing 80.0 kg (176.0 pounds)

Reactions: Cardiac Failure, Atrioventricular Block, Cardiomyopathy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Herceptin

Possible Herceptin side effects in female

Reported by a physician from France on 2012-06-12

Patient: female, weighing 63.0 kg (138.6 pounds)

Reactions: Subdural Haematoma, Cardiac Failure

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Aspirin
    Indication: Cardiac Failure

Herceptin
    Indication: Breast Cancer
    End date: 2012-02-08

Herceptin
    Start date: 2012-04-06

Possible Herceptin side effects in 55 year old male

Reported by a individual with unspecified qualification from Brazil on 2012-06-12

Patient: 55 year old male

Reactions: Death, Vomiting, Nausea, Peripheral Sensory Neuropathy, Disease Progression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Herceptin
    End date: 2011-04-30

Herceptin
    Indication: Gastric Cancer
    Start date: 2010-11-15

Other drugs received by patient: Fluorouracil; Fluorouracil; Leucovorin Calcium; Oxaliplatin

Possible Herceptin side effects in female

Reported by a individual with unspecified qualification from Philippines on 2012-06-08

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Duodenal Ulcer, Hepatic Failure, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Ciprofloxacin; Fluconazole; Tinzaparin; Acetaminophen; Omeprazole; Mucosta; Tranexamic Acid; Vitamin K TAB

Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-06-08

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Cardio-Respiratory Arrest, Pneumonia, Hepatic Failure, Duodenal Ulcer, Febrile Neutropenia, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Ciprofloxacin; Acetaminophen; Mucosta; Omeprazole; Fluconazole; Vitamin K TAB; Tinzaparin; Tranexamic Acid

Possible Herceptin side effects in female

Reported by a physician from Philippines on 2012-06-07

Patient: female, weighing 52.5 kg (115.5 pounds)

Reactions: Gastrointestinal Ulcer, Pneumonia, Cardio-Respiratory Arrest, Hepatic Failure, Febrile Neutropenia, Duodenal Ulcer, Neutropenia

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Docetaxel
    Dosage: last dose prior to sae 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Herceptin
    Dosage: last dose prior to sae : 26 oct 2010, permanently discontinued on 16 nov 2010
    Indication: Breast Cancer
    Start date: 2010-10-26
    End date: 2010-11-16

Other drugs received by patient: Omeprazole; Ciprofloxacin; Fluconazole; Acetaminophen; Tinzaparin; Vitamin K TAB; Mucosta; Tranexamic Acid

Possible Herceptin side effects in 61 year old female

Reported by a physician from United States on 2012-06-07

Patient: 61 year old female

Reactions: Acute Lymphocytic Leukaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Adriamycin PFS
    Indication: Breast Cancer
    Start date: 2000-01-01

Cytoxan
    Indication: Breast Cancer
    Start date: 2000-01-01

Herceptin
    Indication: Breast Cancer
    Start date: 2000-01-01
    End date: 2002-01-01

Taxol
    Indication: Breast Cancer
    Start date: 2000-01-01
    End date: 2002-01-01